Codiak BioSciences Inc (CDAK) Stock Falls -60.00% This Week: Is It a Good Pick?
Tuesday, March 28, 2023 10:02 AM | InvestorsObserver Analysts
Mentioned in this article
Codiak BioSciences Inc (CDAK) stock has fallen -96.41% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CDAK stock a score of 30 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 0. CDAK's rank also includes a long-term technical score of 1.
CDAK has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on CDAK!
Codiak BioSciences Inc (CDAK) stock is up 3.36% while the S&P 500 has fallen -0.23% as of 10:02 AM on Tuesday, Mar 28. CDAK has gained $0.01 from the previous closing price of $0.19 on volume of 4,330,719 shares. Over the past year the S&P 500 is lower by -13.27% while CDAK has fallen -96.41%. CDAK lost -$0.68 per share in the over the last 12 months.
Click Here to get the full Stock Report for Codiak BioSciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter